Tissue crosslinking for treatment of snoring and obstructive sleep apnea
US9918870B2 · kind B2 · utility
1Cited by
13References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2015 |
| Grant date | Mar 20, 2018 |
| Priority date | — |
| Expiry date | Nov 7, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/1028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.